Clinical Trial Update: Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol [Phase 3]

View source ↗

Summary

This is a completed Phase 3 trial comparing levalbuterol to racemic albuterol for the prevention of exercise-induced bronchoconstriction in individuals with ast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Exercise-induced Bronchoconstriction

Drugs mentioned

• Albuterol (racemic) (albuterol)
• Xopenex (Levalbuterol) (Levalbuterol)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Asthma, Bronchoconstriction | Phase 3 | Status: COMPLETED